A. Hirakawa, J. Asano, Hiroyuki Sato, H. Hashimoto, S. Teramukai
{"title":"癌症临床试验的贝叶斯篮子设计","authors":"A. Hirakawa, J. Asano, Hiroyuki Sato, H. Hashimoto, S. Teramukai","doi":"10.5691/JJB.39.103","DOIUrl":null,"url":null,"abstract":"平川晃弘∗1・浅野淳一∗2・佐藤宏征∗3・橋本大哉∗4・手良向 聡∗5 Akihiro Hirakawa∗1 , Junichi Asano∗2 , Hiroyuki Sato∗3 , Hiroya Hashimoto∗4 and Satoshi Teramukai∗5 ∗1東京大学大学院 医学系研究科 生物統計情報学講座 ∗2独立行政法人 医薬品医療機器総合機構 新薬審査第四部 ∗3独立行政法人 医薬品医療機器総合機構 新薬審査第五部 ∗4国立病院機構 名古屋医療センター 臨床研究センター 臨床研究企画管理部 ∗5京都府立医科大学大学院医学研究科 生物統計学 ∗1Department of Biostatistics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan ∗2Office of New Drug IV, Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan ∗3Office of New Drug V, Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan ∗4Department of Clinical Research Management, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya 460-0001, Japan ∗5Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan e-mail:hirakawa@m.u-tokyo.ac.jp","PeriodicalId":365545,"journal":{"name":"Japanese journal of biometrics","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Bayesian Basket Designs for Cancer Clinical Trials\",\"authors\":\"A. Hirakawa, J. Asano, Hiroyuki Sato, H. Hashimoto, S. Teramukai\",\"doi\":\"10.5691/JJB.39.103\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"平川晃弘∗1・浅野淳一∗2・佐藤宏征∗3・橋本大哉∗4・手良向 聡∗5 Akihiro Hirakawa∗1 , Junichi Asano∗2 , Hiroyuki Sato∗3 , Hiroya Hashimoto∗4 and Satoshi Teramukai∗5 ∗1東京大学大学院 医学系研究科 生物統計情報学講座 ∗2独立行政法人 医薬品医療機器総合機構 新薬審査第四部 ∗3独立行政法人 医薬品医療機器総合機構 新薬審査第五部 ∗4国立病院機構 名古屋医療センター 臨床研究センター 臨床研究企画管理部 ∗5京都府立医科大学大学院医学研究科 生物統計学 ∗1Department of Biostatistics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan ∗2Office of New Drug IV, Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan ∗3Office of New Drug V, Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan ∗4Department of Clinical Research Management, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya 460-0001, Japan ∗5Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan e-mail:hirakawa@m.u-tokyo.ac.jp\",\"PeriodicalId\":365545,\"journal\":{\"name\":\"Japanese journal of biometrics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Japanese journal of biometrics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5691/JJB.39.103\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Japanese journal of biometrics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5691/JJB.39.103","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
平川晃弘∗1・浅野淳一∗2・佐藤宏征∗3・橋本大哉∗4・手良向 聡∗5 Akihiro Hirakawa∗1 , Junichi Asano∗2 , Hiroyuki Sato∗3 , Hiroya Hashimoto∗4 and Satoshi Teramukai∗5 ∗1東京大学大学院 医学系研究科 生物統計情報学講座 ∗2独立行政法人 医薬品医療機器総合機構 新薬審査第四部 ∗3独立行政法人 医薬品医療機器総合機構 新薬審査第五部 ∗4国立病院機構 名古屋医療センター 臨床研究センター 臨床研究企画管理部 ∗5京都府立医科大学大学院医学研究科 生物統計学 ∗1Department of Biostatistics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan ∗2Office of New Drug IV, Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan ∗3Office of New Drug V, Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan ∗4Department of Clinical Research Management, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya 460-0001, Japan ∗5Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan e-mail:hirakawa@m.u-tokyo.ac.jp
Bayesian Basket Designs for Cancer Clinical Trials
平川晃弘∗1・浅野淳一∗2・佐藤宏征∗3・橋本大哉∗4・手良向 聡∗5 Akihiro Hirakawa∗1 , Junichi Asano∗2 , Hiroyuki Sato∗3 , Hiroya Hashimoto∗4 and Satoshi Teramukai∗5 ∗1東京大学大学院 医学系研究科 生物統計情報学講座 ∗2独立行政法人 医薬品医療機器総合機構 新薬審査第四部 ∗3独立行政法人 医薬品医療機器総合機構 新薬審査第五部 ∗4国立病院機構 名古屋医療センター 臨床研究センター 臨床研究企画管理部 ∗5京都府立医科大学大学院医学研究科 生物統計学 ∗1Department of Biostatistics and Bioinformatics, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan ∗2Office of New Drug IV, Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan ∗3Office of New Drug V, Pharmaceuticals and Medical Devices Agency, Tokyo 100-0013, Japan ∗4Department of Clinical Research Management, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya 460-0001, Japan ∗5Department of Biostatistics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto 602-8566, Japan e-mail:hirakawa@m.u-tokyo.ac.jp